Navigation Links
Repair Stem Cell Institute Weighs in on Reversal of Embryonic Stem Cell Policy
Date:3/12/2009

The Chairman of the Repair Stem Cell Institute says the viability of Embryonic Stem Cells is an Illusion. Repair (Adult) Stem Cells have swept to such a large lead in diseases being treated all over the world, that it will be impossible for embryonic stem cell research, with all the insurmountable problems, to catch up -- ever.

Bangkok (PRWEB) March 12, 2009 -- Don Margolis, the retired founder of the world's first adult stem cell treatment company and chairman of the Repair Stem Cell Institute (RSCI), today issued a statement from RSCI headquarters in Bangkok, Thailand, in response to President Obama's reversal of current U.S. policy on stem cell research. In it, Margolis said that "Science itself will destroy the illusion of the viability of embryonic stem cells."

Adult Stem Cells have already been proven to safely treat and improve the quality of life for thousands of patients, with successful treatments for multiple sclerosis, heart conditions, optic nerve disorders, diabetes and 100+ other treatable conditions.

Margolis went on to explain "There are six reasons why Embryonic Stem Cells will never make it out of the lab and into the bodies of sick Americans."

Reason one, there is no need for still-useless embryonics. "We already have Repair (Adult) Stem Cells, the most powerful medicine the world has ever seen, capable now of improving the quality of life of millions of patients; something embryonics will never even approach, let alone reach.

Second, no scientist in the world, not just America, has a clue on how to stop the inevitable cancer threat of ESC.

Third, our bodies are built to destroy invading enemies. ESCs are so perceived by the human immune system and always will be.

Fourth, California, with $275 million of stem cell funding to give away last spring, could not find one embryonic scientist in the state who was worthy of two cents worth of funding.

Fifth, there are many ways of creating "embryonic-like" stem cells good for lab research, by using what The Institute heartily endorses, adult cells.

Sixth, economics: there is no way anyone can make money from the disaster known as embryonics. Just ask those who tried to cash in on the Geron hype a few weeks ago."

If a loved one suffers from something "incurable," check out our list of highly-honored doctors and the 100+ diseases they are treating in 2009, NOT 2025."

Mr. Margolis concluded: "For a full explanation of each of these six points, read "The Grim Fairy Tale" on our website.

About the Repair Stem Cell Institute (RSCI): The Repair Stem Cell Institute's mission is to educate and inform everyone about the rapid advances being made in Repair Stem Cell research, so all can intelligently exercise freedom of choice in medical care. Founded in 2008, RSCI is located in Bangkok, Thailand, and Dallas, Texas.

###

Read the full story at http://www.prweb.com/releases/2009/03/prweb2228644.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery
2. Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures
3. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
4. BioSyntech Achieves Enrolment Goal for Pivotal Trial of BST-CarGel(R), its Cartilage Repair Device
5. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
6. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
7. Stem Cell Profits Five Years Away, Says Repair Stem Cell Institute Chairman to The Wall Street Transcript
8. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
9. Repair Stem Cell Institute Announces Science Advisory Board
10. Worldwide Center for Adult Stem Cell Education LLC Changes Name to The Repair Stem Cell Institute LLC
11. Real-time observation of the DNA-repair mechanism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... 22, 2017 , ... Researchers face a fundamental challenge as ... full-size tissues, bones, even whole organs to implant in people to treat disease ... into the developing tissue. , Current bioengineering techniques, including 3-D printing, can’t ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
(Date:3/22/2017)... 22, 2017 The global chronic ... research report by Transparency Market Research (TMR). The top ... and AbbVie Inc., accounted for a share of only ... in this market are focusing aggressively on mergers, acquisitions, ... is likely to lead to market consolidation in the ...
(Date:3/22/2017)... Mass. , March 22, 2017   Boston ... next-generation cancer therapeutics designed to target cancer stemness pathways, ... Patricia S. Andrews as Chief Executive Officer, effective ... succeed Chiang J. Li , M.D., FACP, who ... ten years ago. Under his leadership, Boston Biomedical has ...
Breaking Biology Technology:
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)... 27. Februar 2017  EyeLock LLC, ein marktführendes Unternehmen ... erstklassige biometrische Lösung zur Iris-Erkennung auf der ... LTE auf dem Mobile World Congress 2017 ... in Halle 3, Stand 3E10, vorstellen. ... Qualcomm Haven™ – eine Kombination aus Hardware, ...
Breaking Biology News(10 mins):